Ear Diseases (Disease, Ear)

11/27/2015 - "In a high risk population, our study was unable to demonstrate efficacy of 23vPPV in pregnancy against the co-primary outcomes of either all-cause infant ear disease or 23vPPV-type nasopharyngeal carriage at age 7 months. "

05/01/1989 - "Ciprofloxacin has been shown to be effective in the management of chronic ear disease."
05/01/1989 - "To evaluate the role of ciprofloxacin in the treatment of chronic ear disease, 21 patients who failed routine therapy for chronic ear disease were prospectively treated with oral ciprofloxacin. "
05/01/1989 - "Ciprofloxacin for the treatment of chronic ear disease."
12/01/1995 - "To determine and compare the therapeutic efficiency of ciprofloxacin hydrochloride and gentamicin sulfate in the treatment of chronic ear disease. "

11/01/2012 - "They were middle-aged adults with underlying otologic diseases and were treated successfully with clarithromycin-based combination regimens for 3 and 9 months, respectively."

11/27/2015 - "Efficacy against ear disease concurrent with carriage of vaccine-related serotypes (a more specific outcome) suggests 23vPPV in pregnancy may complement childhood pneumococcal vaccination programs."

01/01/1996 - "Type II collagen-induced autoimmune ear disease in mice: a preliminary report on an epitope of the type II collagen molecule that induced inner ear lesions."
03/01/1986 - "These findings do not support previously reported observations that type II collagen autoimmunity results in ear disease."
05/01/1985 - "In 1981, the authors described a type II collagen-induced autoimmune ear disease (CIAED) model. "
07/01/2002 - "Autoimmune ear disease induced by type II collagen has been investigated by Yoo et al. In the present study, we investigated the effects of direct chronic infusion of type II collagen-specific monoclonal antibodies into guinea pig cochlea. "
01/01/1996 - "To identify the epitope on the type II collagen molecule that induced autoimmune ear disease, electrophysiological and histological studies were carried out in DBA/1J mice immunized with native chick type II collagen (Clln) and cyanogen bromide (CNBr) peptide 1I (CB-I1 peptide) that was cleaved from chicken type II collagen with CNBr digestion. "

09/01/1998 - "The use of prophylactic antibiotics in surgery for chronic ear disease cannot be recommended based on the findings of this study."
09/01/1998 - "The current study was designed to evaluate the role of prophylactic antibiotics in the outcomes of surgery for chronic ear disease. "
08/01/2012 - "The patient was initially treated with antibiotics, and she later underwent a mastoidectomy to clear the ear disease. "
01/01/2001 - "Since the advent of antibiotics, endocranial complications due to infectious ear disease are actually unfrequent. "
06/01/2000 - "Use of ototopical antibiotics in treating 3 common ear diseases."

01/01/1996 - "To identify the epitope on the type II collagen molecule that induced autoimmune ear disease, electrophysiological and histological studies were carried out in DBA/1J mice immunized with native chick type II collagen (Clln) and cyanogen bromide (CNBr) peptide 1I (CB-I1 peptide) that was cleaved from chicken type II collagen with CNBr digestion. "
07/01/2001 - "B10.RIII (H-2r) mice were orally administered cyanogen bromide peptide 11 (CB11) or cholera toxin B (CTB)-conjugated CB11 to induce tolerance in collagen-induced autoimmune ear disease. "

09/15/1969 - "[Clinical studies on the use of torecan in ear diseases]."

06/14/2012 - "Traditionally it is used to treat various diseases like asthma, indigestion, ear diseases, irregular menstruation, skin diseases, piles, fractured bones, etc. This study aimed to evaluate the ability of the plant extracts to inhibit cycloxygenase (COX-1), cycloxygenase (COX-2), and 5-lipoxygenase (5-LOX) enzyme activity. "

06/14/2012 - "Traditionally it is used to treat various diseases like asthma, indigestion, ear diseases, irregular menstruation, skin diseases, piles, fractured bones, etc. This study aimed to evaluate the ability of the plant extracts to inhibit cycloxygenase (COX-1), cycloxygenase (COX-2), and 5-lipoxygenase (5-LOX) enzyme activity. "

04/01/2012 - "WATF measures were obtained in an MEE group of 44 children (53 ears; median age, 1.3 years) scheduled for middle-ear ventilation tube placement and a normal age-matched control group of 44 children (59 ears; median age, 1.2 years) with normal pneumatic otoscopic findings and no history of ear disease or middle-ear surgery. "
11/01/2007 - "Charts were reviewed to identify patients diagnosed with either a congenital syndrome or multiple major malformations with a known association with the development of chronic ear disease who underwent ear surgery for chronic ear disease (excluding tympanostomy tube placement). "
04/01/2006 - "No difference could be seen between those who had had episodes of ear disease but no treatment with tympanostomy tubes and those who had had no documented ear disease. "
04/01/2006 - "The prevalence of elevated thresholds in audiometric screening at conscription was compared for the group of boys who had been treated with tympanostomy tubes and the group of boys with no history of ear disease. "
05/01/1988 - "Cleft type did not influence the degree of ear disease although more patients with complete clefts had a history of repeated grommet insertion. "

06/01/2004 - "The purpose of this study was to evaluate the value and effectiveness of a direct referral hearing aid clinic (DRHAC) in providing appropriate hearing aids to young patients aged 18-60 years while at the same time identifying patients with significant ear disease who need an otologist's opinion. "
04/01/1991 - "This is based on the assumption that very few patients referred for hearing aids have significant ear disease and it is not necessary for them to see an ENT specialist. "
11/01/1967 - "[The construction of hearing aids for ear diseases]."
01/01/2013 - "Hearing aids work well for some while for others; it may not be a perfect solution due to many reasons such as some people do not buy aids that meet their needs, incorrect amplification adjustments, low custom design, etc. In classics of Ayurveda this ailment has been described as karnabaadhirya under the heading of ear diseases. "
11/01/1983 - "Inadvertent placement of molding for a hearing aid in the middle ear space caused symptoms of chronic ear disease, including pain, otorrhea, vertigo, and progressive neurosensory hearing loss. "

08/01/1965 - "ADENOIDECTOMY: INDICATIONS AND TECHNIQUE IN OTOLOGIC DISEASE."
06/01/1997 - "The study included 44 children with bilateral effusive otitis media and 32 children without ear disease, all of whom were scheduled for adenoidectomy. "

09/01/2009 - "This prospective clinical study investigated how far fiber-guided laser ablation of the posterior half of the epipharyngeal tubal ostium led to better middle ear ventilation in the otologic disease patterns mentioned below. "

01/01/2014 - "Surgical procedures for chronic ear disease can be grossly divided into two tympanoplasty procedures: canal wall-up and canal wall-down (CWD) mastoidectomies. "
03/01/2004 - "Development of persistent ipsilateral otological disease requiring a subsequent ipsilateral procedure was approximately twice as common in the tympanoplasty group. "
09/01/1987 - "Poor eustachian tube function and prevalence of infectious ear disease are thought to be the reasons for less successful outcome associated with tympanoplasty in children. "
08/01/1979 - "Mastoidectomy is required in more advanced chronic ear disease; if disease is not too extensive, hearing may be restored by tympanoplasty."
08/01/1978 - "Tympanoplasty is a surgical procedure that has been used in various modifications for the last 25 years for chronic ear disease. "